title: ABCC2 and clinical outcome of tamoxifen therapy.
authors.forename: Thomas
authors.initials: T
authors.lastname: Lang
authors.forename: Werner
authors.initials: W
authors.lastname: Schroth
authors.forename: Hiltrud
authors.initials: H
authors.lastname: Brauch
authors.forename: Matthias
authors.initials: M
authors.lastname: Schwab
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D013629:Tamoxifen
chemical_list: D018931:Antineoplastic Agents, Hormonal; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D013629:Tamoxifen; C000715087:ABCC2 protein, human